Antisense Oligodeoxynucleotide Inhibits the Expression of Cyclin D 1 and Its Influence on Growth of Melanoma Cells

Qianjin Lu,Xian-shi Su,Jiahui Xia,Qi‐you Wei,Qiliang Zhang,Zhenming Wang,Hecheng Zhu,Jiaqi Shi,Bai-Ying Huang,Yun Zhao
1999-01-01
Abstract:Objective To explore the therapeutic potential of antisense oligodeoxynucleotide to cyclin D1 for malignant melanoma. Methods Three 20-mers phosphorothioate oligodeoxynucleotides (ODNs) were synthesized: (1)Cyclin D1 antisense ODN (AS-ODN) targeting the initiation site of translation in cyclin D1 mRNA;(2)Cyclin D1 sense ODN(S ODN) homologous to the initiation site of translation in cyclin D1 mRNA;(3)Random ODN (R-ODN). The level of cyclin D1 mRNA was observed by RT-PCR. The level of cyclin D1 protein and the distribution of cell cycle progression were examined by flow cytometry. The inhibitory effect of ODN for the growth of melanoma (B16) cells was observed by solid green staining and colony forming inhibitory test. Results AS ODN inhibited obviously the level of cyclin D1 mRNA expression while S-ODN and R-ODN did not. The level of cyclin D1 protein was significantly lower in AS-ODN treated cells than that in controls (P 0.05). AS-ODN inhibited B16 cells entering S phase from G1 phase, however, both S-ODN and R-ODN had no such effect. Cells treated with AS-ODN, S-ODN, R-ODN displayed a colony forming inhibitory rate of 63.64%, 18.19%, and 31.82%, and a cell growth inhibitory rate of 64.73%, 26.51%, and 29.64%, respectively. Conclusion Cyclin D1 antisense oligodeoxynucleotide has strong inhibitory effect on the growth of melanoma cells. Key words: Melanoma; Oligodeoxynucleotide,antisense; Cyclins
What problem does this paper attempt to address?